Colorectal Cancer – Epidemiology – Middle East and Africa

Clarivate Epidemiology’s coverage of colorectal cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of colorectal cancer for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered in this report. In addition to forecasting incident and prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy.

Clarivate Epidemiology’s colorectal cancer forecast will answer the following questions:

• How will changes in the levels of exposure to known risk or protective factors affect the number of people who develop colorectal cancer each year?
• How will the declining risk of recurrence change the number of people diagnosed with colorectal cancer each year?
• Of all people diagnosed with colorectal cancer, how many in each country in the developed world are drug-treated?
• How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of colorectal cancer over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods. In addition, we provide a graph depicting the patient flow between or within different disease states for the countries considered in this report. These patient-flow diagrams are provided at the regional level but may be requested for any specific country or forecast year.

In total, Clarivate Epidemiology forecasts 86 colorectal cancer patient populations, including the following:

• Diagnosed incident cases of colorectal cancer.
• Diagnosed incident cases of stage I colorectal cancer.
• Diagnosed incident cases of stage II colorectal cancer.
• Diagnosed incident cases of stage III colorectal cancer.
• Diagnosed incident cases of stage IV colorectal cancer.
• Diagnosed prevalent cases of colorectal cancer.
• Diagnosed incident cases of metastatic recurrent colorectal cancer.
• Diagnosed drug-treatable first-line metastatic colorectal cancer population.
• … and many more (details available on request).

Note: Coverage may vary by country.